يعرض 1 - 14 نتائج من 14 نتيجة بحث عن '"follitropin/cb [Drug Combination]"', وقت الاستعلام: 0.53s تنقيح النتائج
  1. 1
    Electronic Resource
  2. 2
    Electronic Resource

    المؤلفون: McLachlan R.I.

    مصطلحات الفهرس: hormone deficiency/et [Etiology], human, hypogonadotropic hypogonadism/cn [Congenital Disorder], hypogonadotropic hypogonadism/dm [Disease Management], hypogonadotropic hypogonadism/dt [Drug Therapy], hypogonadotropic hypogonadism/et [Etiology], hypothalamus hypophysis gonad system, male infertility/dm [Disease Management], male infertility/dt [Drug Therapy], male infertility/et [Etiology], nonhuman, pseudohermaphroditism/et [Etiology], pulsatile drug release, review, sexual development, skin disease/si [Side Effect], spermatogenesis, virilization, androgen/dt [Drug Therapy], androgen receptor/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ad [Drug Administration], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/dt [Drug Therapy], chorionic gonadotropin/im [Intramuscular Drug Administration], chorionic gonadotropin/pk [Pharmacokinetics], chorionic gonadotropin/sc [Subcutaneous Drug Administration], follitropin/cb [Drug Combination], follitropin/do [Drug Dose], follitropin/dt [Drug Therapy], follitropin/pd [Pharmacology], follitropin/sc [Subcutaneous Drug Administration], follitropin receptor/ec [Endogenous Compound], gonadorelin/cm [Drug Comparison], gonadorelin/dt [Drug Therapy], gonadorelin/pr [Pharmaceutics], gonadorelin/pe [Pharmacoeconomics], gonadorelin receptor/ec [Endogenous Compound], gonadotropin/cm [Drug Comparison], gonadotropin/dt [Drug Therapy], gonadotropin/pe [Pharmacoeconomics], gonadotropin receptor/ec [Endogenous Compound], luteinizing hormone/cm [Drug Comparison], luteinizing hormone/dt [Drug Therapy], luteinizing hormone receptor/ec [Endogenous Compound], testosterone/dt [Drug Therapy], testosterone/pd [Pharmacology], steroid/dt [Drug Therapy], androgen release, delayed puberty/et [Etiology], dose response, drug activity, drug cost, drug half life, endocrine disease/et [Etiology], gene mutation, genetic disorder, gonadotropin release, gynecomastia/si [Side Effect], hormonal regulation, hormonal therapy, Review

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33363
    Click here for full text options
    LibKey Link

  3. 3
    Electronic Resource
  4. 4
    Electronic Resource

    URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32077
    Click here for full text options
    LibKey Link

  5. 5
    Electronic Resource
  6. 6
    Electronic Resource
  7. 7
    Electronic Resource

    المؤلفون: McLachlan R.I.

    مصطلحات الفهرس: hormone deficiency/et [Etiology], human, hypogonadotropic hypogonadism/cn [Congenital Disorder], hypogonadotropic hypogonadism/dm [Disease Management], hypogonadotropic hypogonadism/dt [Drug Therapy], hypogonadotropic hypogonadism/et [Etiology], hypothalamus hypophysis gonad system, male infertility/dm [Disease Management], male infertility/dt [Drug Therapy], male infertility/et [Etiology], nonhuman, pseudohermaphroditism/et [Etiology], pulsatile drug release, review, sexual development, skin disease/si [Side Effect], spermatogenesis, virilization, androgen/dt [Drug Therapy], androgen receptor/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ad [Drug Administration], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/dt [Drug Therapy], chorionic gonadotropin/im [Intramuscular Drug Administration], chorionic gonadotropin/pk [Pharmacokinetics], chorionic gonadotropin/sc [Subcutaneous Drug Administration], follitropin/cb [Drug Combination], follitropin/do [Drug Dose], follitropin/dt [Drug Therapy], follitropin/pd [Pharmacology], follitropin/sc [Subcutaneous Drug Administration], follitropin receptor/ec [Endogenous Compound], gonadorelin/cm [Drug Comparison], gonadorelin/dt [Drug Therapy], gonadorelin/pr [Pharmaceutics], gonadorelin/pe [Pharmacoeconomics], gonadorelin receptor/ec [Endogenous Compound], gonadotropin/cm [Drug Comparison], gonadotropin/dt [Drug Therapy], gonadotropin/pe [Pharmacoeconomics], gonadotropin receptor/ec [Endogenous Compound], luteinizing hormone/cm [Drug Comparison], luteinizing hormone/dt [Drug Therapy], luteinizing hormone receptor/ec [Endogenous Compound], testosterone/dt [Drug Therapy], testosterone/pd [Pharmacology], steroid/dt [Drug Therapy], androgen release, delayed puberty/et [Etiology], dose response, drug activity, drug cost, drug half life, endocrine disease/et [Etiology], gene mutation, genetic disorder, gonadotropin release, gynecomastia/si [Side Effect], hormonal regulation, hormonal therapy, Review

  8. 8
  9. 9
    Electronic Resource
  10. 10
    Electronic Resource
  11. 11
    Electronic Resource

    مصطلحات الفهرس: drug blood level, drug effect, germ cell, gynecomastia/si [Side Effect], hormonal contraception, hormonal regulation, hormone response, human, human experiment, injection, male, normal human, protein blood level, randomized controlled trial, single drug dose, spermatogenesis, spermatozoon count, biological marker/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ct [Clinical Trial], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/cr [Drug Concentration], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/pd [Pharmacology], chorionic gonadotropin/sc [Subcutaneous Drug Administration], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/pd [Pharmacology], inhibin B/ec [Endogenous Compound], medroxyprogesterone acetate/ct [Clinical Trial], recombinant follitropin/do [Drug Dose], recombinant follitropin/pd [Pharmacology], recombinant follitropin/sc [Subcutaneous Drug Administration], steroid hormone/ct [Clinical Trial], steroid hormone/cb [Drug Combination], steroid hormone/cr [Drug Concentration], steroid hormone/dl [Intradermal Drug Administration], steroid hormone/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/cr [Drug Concentration], testosterone/dl [Intradermal Drug Administration], testosterone/pd [Pharmacology], testosterone ester/ct [Clinical Trial], testosterone/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/im [Intramuscular Drug Administration], medroxyprogesterone acetate/pd [Pharmacology], protein subunit/ec [Endogenous Compound], recombinant follitropin/ae [Adverse Drug Reaction], recombinant follitropin/ct [Clinical Trial], recombinant follitropin/cb [Drug Combination], recombinant follitropin/cm [Drug Comparison], recombinant follitropin/cr [Drug Concentration], adult, article, clinical trial, controlled clinical trial, controlled study, dose time effect relation, Article

    URL: Human Reproduction
    Click here for full text options
    LibKey Link

  12. 12
    Electronic Resource

    مصطلحات الفهرس: drug blood level, drug effect, germ cell, gynecomastia/si [Side Effect], hormonal contraception, hormonal regulation, hormone response, human, human experiment, injection, male, normal human, protein blood level, randomized controlled trial, single drug dose, spermatogenesis, spermatozoon count, biological marker/ec [Endogenous Compound], chorionic gonadotropin/ae [Adverse Drug Reaction], chorionic gonadotropin/ct [Clinical Trial], chorionic gonadotropin/cb [Drug Combination], chorionic gonadotropin/cm [Drug Comparison], chorionic gonadotropin/cr [Drug Concentration], chorionic gonadotropin/do [Drug Dose], chorionic gonadotropin/pd [Pharmacology], chorionic gonadotropin/sc [Subcutaneous Drug Administration], gestagen/ct [Clinical Trial], gestagen/cb [Drug Combination], gestagen/pd [Pharmacology], inhibin B/ec [Endogenous Compound], medroxyprogesterone acetate/ct [Clinical Trial], recombinant follitropin/do [Drug Dose], recombinant follitropin/pd [Pharmacology], recombinant follitropin/sc [Subcutaneous Drug Administration], steroid hormone/ct [Clinical Trial], steroid hormone/cb [Drug Combination], steroid hormone/cr [Drug Concentration], steroid hormone/dl [Intradermal Drug Administration], steroid hormone/pd [Pharmacology], testosterone/cb [Drug Combination], testosterone/cr [Drug Concentration], testosterone/dl [Intradermal Drug Administration], testosterone/pd [Pharmacology], testosterone ester/ct [Clinical Trial], testosterone/ct [Clinical Trial], medroxyprogesterone acetate/cb [Drug Combination], medroxyprogesterone acetate/do [Drug Dose], medroxyprogesterone acetate/im [Intramuscular Drug Administration], medroxyprogesterone acetate/pd [Pharmacology], protein subunit/ec [Endogenous Compound], recombinant follitropin/ae [Adverse Drug Reaction], recombinant follitropin/ct [Clinical Trial], recombinant follitropin/cb [Drug Combination], recombinant follitropin/cm [Drug Comparison], recombinant follitropin/cr [Drug Concentration], adult, article, clinical trial, controlled clinical trial, controlled study, dose time effect relation, Article

  13. 13
  14. 14